In our studies, we show that lenalidomide or pomalidomide could effectively target the c-Myc/IRF4 axis, and that once that axis is compromised, MM cells can no longer be rescued from growth inhibition (Figure 4). In addition, our results and those of others7, 8, 9, 17 suggest that ...
Deal Core Patent Clinical Trial Approval Regulation Overview Basic Info Drug Type Monoclonal antibody Synonyms Anti-CD38 monoclonal antibody(Sanofi),Isatuximab,Isatuximab (Genetical Recombination) + [8] Target CD38 Mechanism CD38 inhibitors(Lymphocyte differentiation antigen CD38 inhibitors),ADCC(Antibody-de...